Zimmer Biomet Holdings (STU:ZIM) COGS-to-Revenue : 0.28 (As of Dec. 2023)

View and export this data going back to . Start your Free Trial

What is Zimmer Biomet Holdings COGS-to-Revenue?

Zimmer Biomet Holdings's Cost of Goods Sold for the three months ended in Dec. 2023 was €494 Mil. Its Revenue for the three months ended in Dec. 2023 was €1,779 Mil.

Zimmer Biomet Holdings's COGS to Revenue for the three months ended in Dec. 2023 was 0.28.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Zimmer Biomet Holdings's Gross Margin % for the three months ended in Dec. 2023 was 72.23%.

Zimmer Biomet Holdings COGS-to-Revenue Historical Data

The historical data trend for Zimmer Biomet Holdings's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zimmer Biomet Holdings COGS-to-Revenue Chart

Zimmer Biomet Holdings Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

COGS-to-Revenue

Get a 7-Day Free Trial

0.28

0.30

0.29

0.28

Zimmer Biomet Holdings Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
COGS-to-Revenue	Get a 7-Day Free Trial															0.29	0.27	0.28	0.30	0.28

Zimmer Biomet Holdings COGS-to-Revenue Calculation

Zimmer Biomet Holdings's COGS to Revenue for the fiscal year that ended in Dec. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	1910.844	/	6780.481
	=	0.28

Zimmer Biomet Holdings's COGS to Revenue for the quarter that ended in Dec. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	494.08	/	1779.072
	=	0.28

Zimmer Biomet Holdings (STU:ZIM) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Zimmer Biomet Holdings's Gross Margin % for the three months ended in Dec. 2023 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	494.08 / 1779.072
	=	72.23 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Zimmer Biomet Holdings COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Zimmer Biomet Holdings's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Zimmer Biomet Holdings (STU:ZIM) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Zimmer Biomet Holdings Inc (STU:ZIM) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

ZBH:USA ZBH:Austria

Address

345 East Main Street, Warsaw, IN, USA, 46580

Website

https://www.zimmerbiomet.com

Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two thirds of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.